Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB04871_nanopub.RAAEDa-TftcT7ksBt4sXNyvc5rBBSlnOUIyuO1eP6_gD0#assertion>. }
Showing items 1 to 16 of
16
with 100 items per page.
- drugbank:DB04871 type drugbank_vocabulary:Drug assertion.
- drugbank:DB04871 label "Lorcaserin [drugbank:DB04871]" assertion.
- drugbank:DB04871 seeAlso DB04871 assertion.
- drugbank:DB04871 seeAlso lorcaserin.html assertion.
- drugbank:DB04871 seeAlso belviq-drug.htm assertion.
- drugbank:DB04871 identifier "drugbank:DB04871" assertion.
- drugbank:DB04871 description "Lorcaserin (previously APD-356), a highly selective 5HT2C receptor agonist, is used for the treatment of obesity. It has been shown to reduce body weight and food intake in animal models of obesity, and it is thought that targeting the 5HT2C receptor may alter body weight by regulating satiety. Lorcaserin is marketed as a salt form called Belviq, which is lorcaserin hydrochloride." assertion.
- drugbank:DB04871 title "Lorcaserin" assertion.
- drugbank:DB04871 bio2rdf_vocabulary:identifier "DB04871" assertion.
- drugbank:DB04871 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB04871 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB04871" assertion.
- drugbank:DB04871 bio2rdf_vocabulary:x-identifiers.org DB04871 assertion.
- drugbank:DB04871 drugbank_vocabulary:drugbank-id "DB04871" assertion.
- drugbank:DB04871 drugbank_vocabulary:x-cas cas:616202-92-7 assertion.
- drugbank:DB04871 drugbank_vocabulary:x-kegg kegg:D06613 assertion.
- drugbank:DB04871 drugbank_vocabulary:x-wikipedia wikipedia:Lorcaserin assertion.